Comparative Assessment of Protein Kinase Inhibitors in Public Databases and in PKIDB
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative Assessment of Protein Kinase Inhibitors in Public Databases and in PKIDB
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 14, Pages 3226
Publisher
MDPI AG
Online
2020-07-22
DOI
10.3390/molecules25143226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Properties of FDA-approved small molecule protein kinase inhibitors
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Kinase-targeted cancer therapies: progress, challenges and future directions
- (2018) Khushwant S. Bhullar et al. Molecular Cancer
- PKIDB: A Curated, Annotated and Updated Database of Protein Kinase Inhibitors in Clinical Trials
- (2018) Fabrice Carles et al. MOLECULES
- PubChem 2019 update: improved access to chemical data
- (2018) Sunghwan Kim et al. NUCLEIC ACIDS RESEARCH
- VSPrep: A General KNIME Workflow for the Preparation of Molecules for Virtual Screening
- (2017) José-Manuel Gally et al. Molecular Informatics
- Assessing Scaffold Diversity of Kinase Inhibitors Using Alternative Scaffold Concepts and Estimating the Scaffold Hopping Potential for Different Kinases
- (2017) et al. MOLECULES
- Trastuzumab in the Treatment of Breast Cancer
- (2016) Sofia Maximiano et al. BIODRUGS
- The ChEMBL database in 2017
- (2016) Anna Gaulton et al. NUCLEIC ACIDS RESEARCH
- Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
- (2016) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Current kinase inhibitors cover a tiny fraction of fragment space
- (2015) Hongtao Zhao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Ten things you should know about protein kinases: IUPHAR Review 14
- (2015) Doriano Fabbro et al. BRITISH JOURNAL OF PHARMACOLOGY
- Better Informed Distance Geometry: Using What We Know To Improve Conformation Generation
- (2015) Sereina Riniker et al. Journal of Chemical Information and Modeling
- What does the aromatic ring number mean for drug design?
- (2014) Simon E Ward et al. Expert Opinion on Drug Discovery
- Immune diseases caused by mutations in kinases and components of the ubiquitin system
- (2014) Philip Cohen NATURE IMMUNOLOGY
- Quinazoline-based multi-tyrosine kinase inhibitors: Synthesis, modeling, antitumor and antiangiogenic properties
- (2013) Maria Teresa Conconi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Significance of Chirality in Drug Design and Development
- (2011) W. H. Brooks et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Rule-Based Classification of Chemical Structures by Scaffold
- (2011) Ansgar Schuffenhauer et al. Molecular Informatics
- Dissecting the role of mTOR: Lessons from mTOR inhibitors
- (2009) Ryan J.O. Dowling et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
- (2009) Frank Lovering et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
- (2009) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now